taurine has been researched along with Peritoneal Carcinomatosis in 8 studies
| Excerpt | Relevance | Reference |
|---|---|---|
| "After subcutaneous and intraperitoneal injection of 10(4) cells of colon adenocarcinoma (DHD/K12/TRb) the influences of either taurolidine or taurolidine/heparin on intraperitoneal and subcutaneous tumour growth were investigated in 105 rats undergoing laparoscopy with carbon dioxide." | 3.70 | Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats. ( Braumann, C; Jacobi, CA; Ordemann, J; Wildbrett, P, 2000) |
| "The effect of taurolidine and heparin on growth of colon adenocarcinoma DHD/K12/TRb was measured in vitro and in vivo." | 3.69 | Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model. ( Böhm, B; Jacobi, CA; Müller, JM; Ordemann, J; Sabat, R; Zieren, HU, 1997) |
| " An increasing dosage of TN (from 0." | 1.51 | Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC). ( Arafkas, M; Chaudhry, H; Khosrawipour, T; Khosrawipour, V; Knoefel, WT; Pigazzi, A; Schubert, J, 2019) |
| "Surgical cytoreduction of peritoneal surface malignancy of colorectal origin in combination with hyperthermic intraoperative peritoneal chemotherapy (HIPEC) has become an established treatment approach." | 1.36 | Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model. ( Atanassow, V; Braumann, C; Caldenas, S; Hartmann, J; Kilian, M; Makareinis, A; Raue, W; Schwenk, W, 2010) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (12.50) | 18.2507 |
| 2000's | 5 (62.50) | 29.6817 |
| 2010's | 2 (25.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Schubert, J | 1 |
| Khosrawipour, V | 1 |
| Chaudhry, H | 1 |
| Arafkas, M | 1 |
| Knoefel, WT | 1 |
| Pigazzi, A | 1 |
| Khosrawipour, T | 1 |
| Raue, W | 1 |
| Kilian, M | 1 |
| Braumann, C | 4 |
| Atanassow, V | 1 |
| Makareinis, A | 1 |
| Caldenas, S | 1 |
| Schwenk, W | 1 |
| Hartmann, J | 1 |
| Opitz, I | 1 |
| van der Veen, HC | 1 |
| Ablassmaier, B | 1 |
| Führer, K | 1 |
| Jacobi, CA | 4 |
| Stuhldreier, B | 1 |
| Bobrich, E | 1 |
| Menenakos, C | 1 |
| Rogalla, S | 1 |
| Ordemann, J | 2 |
| Böhm, B | 1 |
| Zieren, HU | 1 |
| Sabat, R | 1 |
| Müller, JM | 1 |
| Volz, J | 1 |
| Volz-Köster, S | 1 |
| Kanis, S | 1 |
| Klee, D | 1 |
| Ahlert, C | 1 |
| Melchert, F | 1 |
| McCourt, M | 1 |
| Wang, JH | 1 |
| Sookhai, S | 1 |
| Redmond, HP | 1 |
| Wildbrett, P | 1 |
8 other studies available for taurine and Peritoneal Carcinomatosis
| Article | Year |
|---|---|
Comparing the cytotoxicity of taurolidine, mitomycin C, and oxaliplatin on the proliferation of in vitro colon carcinoma cells following pressurized intra-peritoneal aerosol chemotherapy (PIPAC).
Topics: Aerosols; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; Cell Proliferation; Colonic Neo | 2019 |
Multimodal approach for treatment of peritoneal surface malignancies in a tumour-bearing rat model.
Topics: Animals; Antimetabolites, Antineoplastic; Cell Line, Tumor; Chemotherapy, Adjuvant; Colonic Neoplasm | 2010 |
The influence of adhesion prophylactic substances and taurolidine/heparin on local recurrence and intraperitoneal tumor growth after laparoscopic-assisted bowel resection of colon carcinoma in a rat model.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Cellulose, Oxidized; Colonic Neoplasms; Disease Mode | 2003 |
High doses of taurolidine inhibit advanced intraperitoneal tumor growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Agents; Biopsy; Cell Division; Cell Line, Tumor; Chemical an | 2005 |
Inhibition of peritoneal tumor cell growth and implantation in laparoscopic surgery in a rat model.
Topics: Adenocarcinoma; Animals; Cell Division; Colonic Neoplasms; Disease Models, Animal; Drug Combinations | 1997 |
Modulation of tumor-induced lethality after pneumoperitoneum in a mouse model.
Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Disease Models, Animal; Fema | 2000 |
Taurolidine inhibits tumor cell growth in vitro and in vivo.
Topics: Adenocarcinoma; Animals; Anti-Infective Agents, Local; Cell Death; Cell Division; Cell Survival; Col | 2000 |
Influence of intraperitoneal and systemic application of taurolidine and taurolidine/heparin during laparoscopy on intraperitoneal and subcutaneous tumour growth in rats.
Topics: Adenocarcinoma; Animals; Antineoplastic Combined Chemotherapy Protocols; Cell Division; Drug Synergi | 2000 |